NeOnc Technologies Holdings is trading 8.5% higher at $2.94 in pre-market, with no clearly linked company-specific catalyst identified.

  • The price compares with the October 7 close of $2.71.
  • Recent coverage discusses previously reported NEO100 results and planned FDA discussions, not a new announcement explaining the move.
  • Major U.S. indices are lower in pre-market trading; no volume was reported, and the reason for the move remains unclear.